Cheers! Why the Future of Cannabis is in Beverages. TSXV:BEER

Similar documents
Investor Presentation

SPECIALTY MEDICAL CANNABIS COMPANY

SPECIALTY MEDICAL CANNABIS COMPANY

Letter to Shareholders

Cannabis Regulation in Canada:

E N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE

TSX Venture: RVV OTCQB: RVVTF

Canopy Growth Corporation

For personal use only

SUBJECT: Cannabis legislation and implications for the City of Burlington

which has been used to help the treatment of epilepsy, seizures, alleviate neuropathic pain and muscular dystrophy.

THE STATE OF THE MEDICAL MARIJUANA MARKETS 2011

The Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation.

BDS ANALYTICS Top Ten Cannabis Market Trends for 2019

420 ADVISORY MANAGEMENT

INVESTOR PRESENTATION

Trip Report February 26, 2019

Responsible Retailing of Recreational Cannabis. Recommendations to British Columbia s Cannabis Regulation Engagement Secretariat

U.S. Medical Cannabis Market Share, Size, Analysis, Growth, Regional Outlook, Trends and Forecasts to 2024 Hexa Research

Investment in MGC Pharmaceuticals

For personal use only

MEDICAL CANNABIS COMPANY

applicable securities laws in Canada. Although the Company believes that the expectations and assumptions on which the forward-looking statements

For personal use only

USPSTF Draft Recommendations Investor Call. October 6, 2015

OUR CANNABIS BUSINESS ROADMAP. November 28 th, 2017

Permitted Cannabis Marketing Activities

Investor Presentation Q4 2018

Cannabis 101: Industry landscape and the road to edibles. Presented by: Glenn Fraser Date: May 10, 2018

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

THE DRINKS MARKET PERFORMANCE. Prepared for the Drinks Industry Group of Ireland By Anthony Foley Dublin City University Business School

Presented by: GEORGE SCORSIS CEO

Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores

INVESTOR PRESENTATION

For personal use only

PRIMARY CONTACT EXECUTIVE DIRECTOR, ATHLETICS, RECREATION AND ANCILLARY SERVICES I. POLICY

Legal Licensing and Compliance in the Commercial Cannabis Industry

Cannabis Regulations Response and Update on Cannabis Legalization

Recreational Marijuana Insights And Opportunities Deloitte

OMA Submission on Health Canada s Proposed Regulations for Additional Cannabis Products. February 2019

Investor Presentation

Our Experience is Growing

MARIJUANA LEGALIZATION. INITIATIVE STATUTE.

Driving While High: Facts and Public Attitudes

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

Enabling Cannabis Retail Stores and Facilities Land Use Bylaw

Guidance for Municipalities Regarding Marijuana for Adult Use January 2018

Cannabis Legalization Proposed Bylaws

Permitted Cannabis Marketing Activities

MICHIGAN MEDICAL MARIJUANA REGULATION: From Home Remedy to Criminalization. to State Regulated Industry. March 22, Stephen K.

The federal legislation, Cannabis Act that legalizes recreational cannabis comes into effect on October 17, 2018.

Investor Presentation Q2 2018

The Cannabis Opportunity. Research Overview

Investor Presentation

Oral semaglutide and production expansion. Henrik Wulff EVP Product Supply. Peter Kristensen SVP Global Development

Food & Beverages Food for a growing world

Update on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council

ALCOHOL POLICY ALCOHOLIC BEVERAGE POLICY

Cannabis Legalization August 22, Ministry of Attorney General Ministry of Finance

OWC Pharmaceutical Research Corp. (OTCQB: OWCP)

Canadian Marijuana Industry Snapshot: 17 Charts

Patrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation

Universal Biosensors, Inc.

Leading Cannabinoid Patient Care in Canada. Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF

Cannabis Retail Regulation and Licence Applications PART 1 NOVEMBER 27, 2018

Michael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation

Tamsulosin Hydrochloride 0.4 mg Capsule

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

For personal use only

EUROPEAN ALCOHOL AND HEALTH FORUM. UK Responsibility Deal pledge on Alcohol Unit Reduction

AMERICAN ROOTS. GLOBAL REACH CSE: TGIF FWB: 1QF OTC: TGIFF

NEW FRONTIER DATA. ALL RIGHTS RESERVED.

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

Cannabis use carries significant health risks, especially for people who use it frequently and or/begin to use it at an early age.

Eaze Insights: The Modern Marijuana Consumer. Study: The modern marijuana consumer

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

Medicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, Kamau Chionesu

Part II: The Marijuana Consumer

MARKET SIZE AND DEMAND 2017 MARKET UPDATE FOR MARIJUANA IN COLORADO. Prepared for the Colorado Department of Revenue

ALCOHOL, CANNABIS, AND TOBACCO

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Experience is growing

Regulating Marijuana in California

RECREATIONAL CANNABIS. Province of British Columbia regulations

Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results Proving Statistically Significant Improvements in Triglycerides & Non-HDL-C

Both news releases were disseminated through Stockwatch. The May 30, 2016, news release was also disseminated through Accesswire.

Higher Ground. Insights from Canada s Most Comprehensive Consumer Cannabis Study. Pat A. Pellegrini, Ph.D. President and CEO Vividata

Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia. -Broadens Roche Nicotinic Alpha-7 Alliance-

Ryan Smith, Community Planning Department Manager

Cannabis Culture Poll. November 2018

BRIEFING: ARGUMENTS AGAINST MINIMUM PRICING FOR ALCOHOL

Q3 18 Earnings Supplemental Slides

B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations

Darrin T. Grondel, Director WA Traffic Safety Commission March 9, 2016

Medical and Recreational Marijuana - Legalization Issues NCCAE Conference

ELECTION NIGHT 2018 HOT SHEET

Cannabis Commerce Association of Canada

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

Transcription:

Cheers! Why the Future of Cannabis is in Beverages TSXV:BEER www.hillstreetbeverages.com

Forward Looking Statements, blah, blah, blah This Presentation may contain statements which constitute forward-looking information, including statements regarding the plans, intentions, beliefs and current expectations of the Company, its directors, or its officers with respect to the future business activities and operating performance of the Company. The words may, would, could, will, intend, plan, anticipate, believe, estimate, expect and similar expressions, as they relate to the Company, or its management, are intended to identify such forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future business activities or performance and involve risks and uncertainties, and that the Company s future business activities may differ materially from those in the forward-looking statements as a result of various factors. First person to yell out, Free Beer! come see me after the talk for a free six pack. Such risks, uncertainties and factors are described in the periodic filings with the Canadian securities regulatory authorities, including the Company s quarterly and annual Management s Discussion & Analysis, which may be viewed on SEDAR at www.sedar.com. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update these forward-looking statements other than as may be required by applicable law. Our lawyer said this stuff is Important.

Watershed: Oct. 2019 Expected Legalization of Cannabis-Infused Edibles Adult-Format Beverages: The Best Delivery Method for Edible Cannabis De-selects minors Matches social, sharing experiences Microdoses mimic onset & duration of effect from beverage alcohol 3. 60-80% Fewer calories No ill effects No hangover

$7B in Canada by 2020*** $55B in USA**** #1 2016 High Times Survey : Beverages are the #1 preferred Delivery format but availability of appealing options is the biggest barrier. 88% $13B to $23B 25% 21% # of millennials believe Alcohol is dangerous Size of Ancillary market 2017 Growth in Edible Sales in US Drop in Alcohol Sales Bloomberg **** Econ. Prof. Alberto Chong, Georgetown U. Deloitte** Forbes* edibles, concentrates and beverages will soon transform into primary consumer products more than the cannabis bud itself. - Euromonitor * https://www.forbes.com/sites/mikeadams/2018/04/19/the-millennial-voice-could-end-federal-marijuana-prohibition/#6027d8253e18 4 ***Source: FinancialPost.com, May 8, 2018, Cannabis Sales to Top Hard Liquor by 2020 ****Source: https://www.bloomberg.com/news/articles/2016-09-12/cannabis-industry-to-expand-to-50-billion-by-2026-analysts-say **Source: Deloitte, 2016, Recreational Marijuana Insights and Opportunities

Fear & Loathing @ Big Alcohol: Loss of share, loss of playbook Significant declines in alcohol consumption where cannabis made legal Molson Coors Legal cannabis now a risk factor (10K 2017) Marijuana sales top annual liquor sales in Aspen, Colorado (2017) Beverage Alcohol playbook cannot be used Drinks with cannabis cannot contain alcohol (or caffeine or nicotine) Cannabis-infused (CI) brands cannot be advertised; levels the playing field The larger the market share in beverage alcohol, the greater the potential volume risk CI-based line extensions from alcoholic brands likely to disappoint (different taste) Opportunity for new brands that resonate with consumers Taste Relevance 5.

An exploding category Beer Domestic production = Alcohol Free +19% - 2.4% Domestic sales = yoy Category Growth *(alcohol free beer, wine, cocktails, mixers, and cider) 55% vs. 34% AF Beer total sales yoy +27%yoy Growth in AF beer yoy Vs. - 0.7% yoy Total national sales = -0.4% yoy Sales per capita over 10 years -10% According to Beer Canada According to Nielsen 6. Infused alcohol free beer and wine are the ideal adult alternative to alcohol

CannaBeverage Plays Constellation Brands (STZ-NYSE) & Canopy (WEED-TSX) August 15 announcement of US$4bn increased stake in Canopy (up to 50%) 2nd investment in Canopy by Constellation Brands (1st investment was US$245m for 9.9% stake) Cannabis as a potentially disruptive ingredient US opportunity of US$50bn today, global opportunity of US$227bn by 2032 (rec & med)* US$11bn Canada, US$96bn US, US$120bn ROW Molson Coors (TAP-NYSE) & Hydropothecary (HEXO-TSX) August 1 announcement of JV between Molson Coors Canada and HEXO Canada gives us a real opportunity to incubate and test it's got really significant potential and we're going to learn a lot. And if other markets start to open up in due course and this becomes federally legal, then we'll be in a good place at that point in time. ** Aurora Cannabis (ACB-TSX) & Alcanna (CLIQ-TSX - formerly Liquor Stores N.A. Ltd.) Feb 5 announcement of C$103.5mn investment for 19.9% stake in Alcanna with option to increase to 40%. (As of May 10, stake increased to 25%). 7. *From Constellation Brands Investment in Canopy Growth Presentation: Expanding our Strategic Partnership August 2018 **Molson Coors Q2 Conference Call transcript

The Current Cannabev Players Ticker Price Market Capitalization (C$MM) Tinley Beverage Co Inc TNY $0.69 $62.7 $0.019 3,275x Koios Beverage Corp KBEV $0.21 $10.2 $0.000 Friday Night Inc TGIF $0.42 $91.4 $9.900 9x Nutritional High International Inc EAT $0.36 $103.3 $1.674 62x Canopy Growth Corp. WEED $52.10 $26,060.6 $87.99 296x Aurora Cannabis Inc. ACB $8.05 $8,301.4 $41.98 198x Aphria Inc. APH $11.25 $2,716.8 $36.92 74x The Green Organic Dutchman TGOD $6.52 $1,620.0 $0.00 Hill Street Beverage Co. BEER $0.32 $30.0 $1.50 20x Edibles and Non-Inhalables TTM Revenue (C$MM) TTM Price/ Sales Licensed Producers 8. Source: Hill Street Beverage Co., Bloomberg LLC

Hill Street Ready to Serve Brand-building management team and Board (beverages/cannabis/ digital marketing) Lexaria agreement 9. 1 of 5 Canadian licences Grants use of technology for odourless, tasteless cannabis-infusion process 13 years Co-packing Experience for Major National Brands Cause-related marketing exclusives with health & charity brands Award-winning products (beers and wines) in ~4,000 stores

Summary End of An Era End of cannabis prohibition is once-in-a-lifetime event Opportunity 10. Proof of concept beverages Regulatory framework for sales and distribution Licensed Producers waking up to the market Taste and experience are primary drivers Consumer switchers from alcohol worth $5Bn Alcohol-free beverages=ideal host products Alcohol sales dropping or stagnant globally Significant health risks with alcohol Lots of producers developing infusion tech Catalysts Marketing and Advertising regulations Consumer awareness of alcohol risks Next steps Copacking and distribution businesses Testing and compliance requirements are high Retail and Foodservice opportunities to come

Terry Donnelly Chairman & CEO terry@hillstreetbevco.com TSXV:BEER www.hillstreetbeverages.com